David Back

InstitutionUniversity of Liverpool
AddressLiverpool
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in August 2020 and October 2020 and December 2020
    All Publications
    Bar chart showing 242 publications over 19 distinct years, with a maximum of 21 publications in 2011
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, Marzolini C, Siccardi M, Burger D, Gibbons S, Khoo S, Back D. Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. Drugs R D. 2021 Mar; 21(1):9-27. PMID: 33336316.
      Citations: 3     Fields:    Translation:Humans
    2. Hodge C, Marra F, Marzolini C, Boyle A, Gibbons S, Siccardi M, Burger D, Back D, Khoo S. Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. J Antimicrob Chemother. 2020 12 01; 75(12):3417-3424. PMID: 32750131.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    3. Boffito M, Back DJ, Flexner C, Sjö P, Blaschke TF, Horby PW, Cattaneo D, Acosta EP, Anderson P, Owen A. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID-19 Therapeutic Development. Clin Pharmacol Ther. 2021 07; 110(1):64-68. PMID: 33113246.
      Citations: 11     Fields:    Translation:HumansCells
    4. Poncette AS, Glauert DL, Mosch L, Braune K, Balzer F, Back DA, Back DA. Undergraduate Medical Competencies in Digital Health and Curricular Module Development: Mixed Methods Study. J Med Internet Res. 2020 10 29; 22(10):e22161. PMID: 33118935.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    5. Stader F, Khoo S, Stoeckle M, Back D, Hirsch HH, Battegay M, Marzolini C. Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086. PMID: 32556272.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    6. Siccardi M, Schapiro J, Di Perri G, Back DJ. The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics. J Antimicrob Chemother. 2020 09 01; 75(9):2381-2383. PMID: 32591771.
      Citations:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Marzolini C, Battegay M, Sendi P, Back DJ. Prescribing in COVID-19 patients: Should we take into account inflammation? Br J Clin Pharmacol. 2021 03; 87(3):719-721. PMID: 32820554.
      Citations:    Fields:    Translation:Humans
    8. Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE. Safety perspectives on presently considered drugs for the treatment of COVID-19. Br J Pharmacol. 2020 10; 177(19):4353-4374. PMID: 32681537.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    9. Arshad U, Pertinez H, Box H, Tatham L, Rajoli RKR, Curley P, Neary M, Sharp J, Liptrott NJ, Valentijn A, David C, Rannard SP, O'Neill PM, Aljayyoussi G, Pennington SH, Ward SA, Hill A, Back DJ, Khoo SH, Bray PG, Biagini GA, Owen A. Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. Clin Pharmacol Ther. 2020 10; 108(4):775-790. PMID: 32438446.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    10. Back D, Marzolini C, Hodge C, Marra F, Boyle A, Gibbons S, Burger D, Khoo S. COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. Br J Clin Pharmacol. 2021 01; 87(1):212-213. PMID: 32384171.
      Citations: 12     Fields:    Translation:Humans